FDA Eli Lilly - Search News

Eli Lilly cuts prices for Zepbound weight-loss drug

Hosted on MSN · 1h

Eli Lilly cuts prices for Zepbound weight-loss drug again

Pharmaceutical giant Eli Lilly is once again expanding the supply of its weight-loss drug Zepbound and cutting the cost for patients that don't have insurance.

Wall Street Journal · 8h

Eli Lilly to Offer Higher Doses of Obesity Drug Zepbound at Discounted Prices

Eli Lilly said it has launched new doses of its obesity treatment drug and reduced its prices.

Lilly offers weight-loss drugs in vials at a discount to fight competition

Eli Lilly has cut the price for vials of its weight-loss drug Zepbound sold online and expanded the range of doses in an attempt to stave off stiff competition from compounding pharmacies and rival Novo Nordisk.

4hon MSN

Why Eli Lilly Stock Popped Today

Eli Lilly ( LLY 2.11%) stock defied today's market downturn, rising 2.6% through 11:15 a.m. ET on the back of two positive ...

Compounders sue FDA again over declaring end of shortage for Novo's semaglutide

Compounding pharmacies aren’t surrendering their ability to create cheaper knockoff versions of Eli Lilly and Novo Nordisk’s ...

Lilly expands its Zepbound vial offering, as Hims pulls back on semaglutide

Lilly expands its Zepbound vial offering, as HIMS pulls back on semaglutide, and other biotech news in today's Readout ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results